Get the latest breakthroughs in cancer treatments including FDA updates on Lorigerlimab, strategies on handling Melanoma toxicities, FDAs Fast Track…
Day: January 14, 2026
Health Canada Approves Pembrolizumab/Surgery for HNSCC | Advancements in Cancer Treatments
Explore the latest advancements in cancer therapies, focusing on Pembrolizumab in HNSCC, immune-checkpoint inhibitors, fast track designations, and other novel…